Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Am J Ophthalmol. 2007 Jun 22;144(2):169–180. doi: 10.1016/j.ajo.2007.05.029

The association of contact lens solution use and Acanthamoeba keratitis

Charlotte E Joslin 1,2, Elmer Y Tu 1, Megan E Shoff 3, Gregory C Booton 4, Paul A Fuerst 3, Timothy T McMahon 1, Robert J Anderson 2, Mark S Dworkin 2, Joel Sugar 1, Faith G Davis 2, Leslie T Stayner 2
PMCID: PMC2692658  NIHMSID: NIHMS28012  PMID: 17588524

Abstract

Purpose

Diagnosis of Acanthamoeba keratitis, a rare but serious corneal infection, has recently increased significantly at the University of Illinois at Chicago (UIC) Cornea Service. The purpose is to investigate Acanthamoeba keratitis risk factors.

Design

Retrospective case-control study.

Methods

Setting

University, tertiary care hospital.

Patients

Fifty-five Acanthamoeba keratitis cases with contact lens use were diagnosed between May 1, 2003 and September 15, 2006. Clinic-matched controls with contact lens use were recruited. Subjects completed surveys targeting lens hygiene, contact lens solution use, and water exposure.

Main Outcome Measure

Acanthamoeba keratitis.

Results

Thirty-nine (73.6%) cases and 113 (65.3%) controls participated; 38 cases had complete contact lens data. Thirty-five of 38 cases (92.1%) and 47 of 100 controls (47.0%) used soft lenses. Analysis was performed on 30 cases and 39 controls with matched pairs with soft lens use. Exclusive use of AMO Complete MoisturePlus Multi-Purpose Solution was independently associated with Acanthamoeba keratitis in multivariable analysis (55.2% vs. 10.5%; OR, 16.67; 95% CI, 2.11–162.63; p = 0.008). However, 38.8% of cases reported no use of AMO Complete MoisturePlus Multi-Purpose Solution or used it in combination with other solutions. Although not statistically significant, additional hygiene-related variables (solution ‘reuse’, lack of ‘rubbing’, and showering with lenses) suggest a pattern of risk,.

Conclusions

AMO Complete MoisturePlus Multi-Purpose Solution use is independently associated with Acanthamoeba keratitis among soft contact lens users. However, it does not explain all cases, suggesting additional factors. Further research into environmental risk factors and hygiene practices is warranted, especially considering this is the second outbreak of an atypical, contact lens-related infection.

Introduction

Acanthamoeba keratitis (AK) is a severe, painful infection of the cornea that usually causes corneal scarring and sometimes blindness. The causative agent, Acanthamoeba, is a ubiquitous free-living amoeba that is believed to contaminate the cornea through exposure to contaminated water, often potentiated by contact lens wear.1 The first published report of confirmed AK was in 1974,2 and through the next decade the infection was considered extremely rare. Disease frequency increased during the 1980’s and temporally paralleled the widespread introduction of soft contact lenses. A 1985 AK outbreak investigation by the Center for Disease Control and Prevention implicated contact lens use as a primary cause,3 and more than 85% of AK cases reported to the CDC between 1973 and 1988 were in contact lens wearers, suggesting that contact lens use is a significant risk factor.4, 5 As further evidence, Acanthamoeba cysts and trophozoites have been shown to adhere to all types of contact lenses,1, 612 suggesting that contact lenses may serve as a vector for disease transmission.1 Other well-known risk factors include poor lens hygiene, contact lens use while swimming, use of certain contact lens disinfection products, and source water contamination.13, 14 Genetic typing of Acanthamoeba isolates from the cornea in previous UK reports has matched Acanthamoeba isolates from the water supply in homes of AK patients.15

Because AK is rare, the epidemiology in the United States is poorly understood. The U.S. annualized incidence has been conservatively estimated to range from 1.65 to 2.01 cases per million contact lens wearers however16 it may be as much as 15 times more common in the UK, Europe and Hong Kong.13, 17, 18

A statistically significant increase in AK cases occurred in the Chicago-area beginning in June 2003,19 with a total of 63 incident cases identified through the end of 2006. This increase is inconsistent with previously understood risk factors, which to our knowledge, are unchanged in frequency.

Acanthamoeba species are largely resistant to most contact lens solutions.2229 Contact lens solutions in 2006 were independently associated with Fusarium keratitis, another rare and serious eye infection that is not normally associated with contact lens use.20

It is important to investigate the potential role of contact lens solutions in AK diagnosis because: 1) questions exists over contact lens solution effectiveness against AK; 2) solution companies are not required to demonstrate effectiveness against Acanthamoeba nor potential interactions between contact lens FDA Lens Group and solutions for FDA approval; and, 3) a specific contact lens solution was independently identified as a risk factor in the Fusarium outbreak. We have previously hypothesized that recently implemented U.S. Environmental Protection Agency (EPA) regulations reducing the allowable amount of carcinogenic disinfection byproducts in the water supply may have shifted the microbial risk balance and increased the risk of AK from tap water exposure.19, 21 This solution risk factor analysis was conducted in conjunction with our ongoing case-control study investigating AK risk factors involving individual surveys and conducting water sampling of homes with laboratory and molecular analysis of identified corneal and environmental Acanthamoeba isolates. The purpose of this analysis is to investigate if use of certain contact lens solutions are associated with AK.

Methods

The University of Illinois at Chicago (UIC) Institutional Review Board reviewed and approved this research.

Disease Definition

Patients with atypical keratitis were defined as AK cases if they had disease resolution with anti-acanthamoebal treatment and at least one or more of the following conditions: 1) identification of trophozoites or cysts on confocal microscopy; 2) identification of trophozoites or cysts through smears when specimens were stained with Diff-Quick stain; 3) positive Acanthamoeba cultures; or, 4) pathology identification of AK on keratoplasty specimens. This definition was chosen based on 1) evaluation of the validity of diagnostic tests within our AK series; 2) confocal microscopy diagnostic sensitivity of 94.3% and specificity of 72% when compared against objective laboratory evidence of disease in a cohort of subjects who had confocal microscopy performed; and, 3) the fact that culture sensitivity in our series was only 51.3% (Tu EY et al. IOVS 2007;48:ARVO E-Abstract 753; AAO 2006:Abstract 455; Tu EY et al, under review, American Journal of Ophthalmology). This low culture positive rate is consistent with large-scale studies in the UK in which culture positive rates ranged from 43% – 54%,13, 22 suggesting loss of cases if restricting to culture positive disease. All confocal microscopy images were re-reviewed at a single sitting prior to study initiation to minimize potential intra-observer variability.

Case Control Definition and Selection

All AK cases diagnosed at the UIC Cornea Service between May 1, 2003 and September 15, 2006 were included in analysis. Cases were restricted to contact lens wearers (n = 55). Potential cases were entered into an Excel-based tracking system and followed until pending diagnostic tests and clinical results confirmed AK status.

Controls were defined as contact lens-wearing patients from the UIC Cornea Service with all other conditions; patients with AK or diseases requiring use of soft bandage contact lenses were excluded as controls. Controls were selected according to patient census data. Controls were restricted to contact lens users and a 1:M variable-matching ratio plan was used to individually match cases to controls according to date of visit (± 1 month) and age (± 5 years). Matching factors were chosen as case age was somewhat bimodal in distribution and age-matching insured adequately-aged controls for analysis; as well, date-of-service was selected to control for potential seasonal variability in exposure to Acanthamoeba-contaminated water (ie, variability in recreational water activities or thermal variability in the water distribution system influencing microbial load due to organism thermotolerance, etc.). Both soft and rigid lens users were eligible.

Data Collection

All subjects were telephoned and invited to participate, and study packets consisting of a survey, water sampling kit and postage-paid return envelope were mailed to subjects who agreed to participate. All subjects signed informed consent documents and returned signed documents through the mail with survey and water sampling packets. Subjects were categorized ‘unable to contact’ if existing home and work telephone numbers were incorrect, or if five or more calls at different times and days of the week did not result in contact. Survey questions were focused on the six-month time period prior to symptom development and targeted three main categories of variables: 1) water exposure; 2) contact lens hygiene (including solutions and lens types); and, 3) habits associated with contact lens use. Color images of all contact lens solution products were included within the survey to assist in memory recall. The six-month time period was assigned for controls, starting from the date of symptom onset in matched cases.

Determination of Contact Lens Solution Product Formulations

Product formulations in solutions common to AK cases were reviewed to determine equivalency within a brand through the FDA 510(k) Premarket Notification Database Search accessed at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm. Findings were reviewed with James Saviola, OD, Chief, Vitreoretinal and Extraocular Devices Branch, Ophthalmic Device Panel, U.S. FDA (personal communication, March 12, 2007). The most recent AMO Complete Multi-Purpose Solution formulation change, ‘Upgrade C’ was approved by the FDA on December 10, 2002 (K023226), and was launched on August 18, 2003 according to the corporate website23 (Advanced Medical Optics, Santa Ana, CA). The present formulation remains the same as the December 2002 formulation, and subsequent approvals have been labeling changes. All AMO Complete multipurpose solutions were treated as the newest formulation for analyses, AMO Complete MoisturePlus Multi-Purpose Solution (hereafter referred to as Complete MoisturePlus) because: 1) most subjects probably used Complete MoisturePlus based on the FDA approval date and market availability; and 2) the product names and images were nearly identical making discrimination between products difficult (AMO Complete MoisturePlus Multi-Purpose Solution vs. AMO Complete Multi-Purpose Solution). Differential reponses were compared over time to determine if they suggested changing market shares over time, and this was not evident.

Statistical Analysis

All statistical analyses were performed using SAS (v. 9.1.3; SAS Institutes, Cary, NC). Analyses were performed on all subjects unless either they or their matched case had missing data on contact lens use or reported no contact lens use during the assigned time period (n: cases = 1, controls = 13; Table 1), in which case they were dropped from further analysis. Descriptive analysis was conducted on all subjects currently enrolled in the case-control study. Analyses were restricted to subjects that used soft contact lenses because soft contact lens use was different between cases and controls. Univariate analysis was performed on this subset of complete matched case-control pairs using exact conditional logistic regression to estimate the odds ratio and 95% confidence intervals; cases or controls without matched pairs were dropped from analyses (Table 3). Exact conditional multivariable logistic regression was performed using forward stepwise addition to assess whether exclusive use of Complete MoisturePlus was associated with AK as compared to use of all other soft contact lens solution products after controlling for confounding variables. Exact unconditional logistic regression was also performed using the same subset of soft lens subjects and compared against exact conditional logistic regression results after controlling for confounding and matching variables, since use of conditional logistic regression in small data sets can produce biased estimates of effects and unconditional methods may yield more stable risk estimates.24, 25 Exclusive use of Complete MoisturePlus was compared to use of all other soft lens solutions including use of multiple solutions because if Complete MoisturePlus was the greatest risk factor, then addition of other solutions to the exposed category would dilute risk compared to exclusive use of Complete MoisturePlus. A sensitivity analysis was performed to address the effects of missing data in regards to use of Complete MoisturePlus in which cases were classified as either exposed or unexposed, and controls were classified oppositely. Analysis was performed on the subset of culture positive cases to similarly confirm the robustness of results.

Table 1.

Acanthamoeba keratitis case-control study participation response and cooperation rates. Response rates include all subjects including those who could not be contacted,* while cooperation rates reflect participation among contacted subjects.

Response Rates Cooperation Rates

Cases:
Acanthamoeba keratitis
Controls:
No Acanthamoeba keratitis
Cases:
Acanthamoeba keratitis
Controls:
No Acanthamoeba keratitis

n % n % Total n % n % Total

‘Unable to contact’* 2 3.6 43 19.9 45
No 14 25.5 60 27.8 74 No 14 26.4 60 34.7 74
Yes 39 70.1 113 52.3 152 Yes 39 73.6 113 65.3 152
Total 55 216 271 Total 53 173 226
*

Subjects were considered ‘unable to contact’ if existing home and work telephone numbers were incorrect, or if five or more calls at different times and days of the week did not result in contact.

152 subjects agreed to participate; subjects were dropped if either they or their matched case had missing data on contact lens use or reported no contact lens use during the assigned time period (n: cases = 1, controls = 13), resulting in a total of 138 subjects (Table 2).

Table 3.

Comparison of demographics and exposures of 30 Acanthamoeba keratitis cases and 39 clinic-matched controls wearing soft contact lenses.

Matched Case-Control Pairs Univariate Analysis

Cases: Controls: 95% CI
Total
N = 30
% Total
n = 39
% Total
n = 69
Conditional OR* Chi-square p-value

Demographics
Sex
 Male 16 53.33 18 46.15 69 1.04 0.26 4.13 0.953
 Female 14 46.67 21 53.86
 Missing 0 0
Age
 13 – <33 21 70.00 20 51.28 69 matching variable
 33 – <53 5 16.67 11 28.21
 53 – 74 4 13.33 8 20.51
 Missing 0 0
General Health:
 Good, fair, poor 8 26.67 18 46.15 69 0.36 0.10 13.57 0.132
 Excellent 22 73.33 21 53.85
 Missing 0 0
Smoking Status:
 Yes 3 10.00 5 12.82 69 1.08 0.17 6.70 0.938
 No 27 90.00 34 87.18
 Missing 0 0

Contact Lens Use and Hygiene
Use Contact Lens:
 >10 times per month 27 90.00 34 87.18 69 2.43 0.26 126.00 0.778
 ≤ 10 times per month 3 10.00 5 12.82
 Missing 0 0
Silicone hydrogel contact lens use:
 Yes 0 0.00 6 28.57 1.04 0.89 2.11 0.812
 No 25 100.00 15 71.43 46
 Missing 5 19
Sleep with contact lens:
 ≥ 1 time per month 7 24.14 11 28.21 68 0.42 0.09 2.07 0.286
 0 times per month 22 75.86 28 71.79
 Missing 1 0
Actual contact lens replacement:
 Quarterly or less frequently 7 25.93 17 50.00 63 0.418 0.13 1.43 0.164
 More frequently than quarterly 20 74.07 17 50.00
 Missing 3 5
Age of case at replacement:
 >3 months 21 70.00 21 53.85 68 2.34 0.74 7.41 0.149
 ≤ 3 months 8 30.00 18 46.15
 Missing 1 0
Reuse solution:
 >5 times per month 17 58.62 10 25.64 68 3.19 1.10 9.27 0.033
 0–5 times per month 12 41.38 29 74.36
 Missing 1 0

Contact Lens Solutions
Solution use
 AMO Complete MoisturePlus product 16 55.17 4 10.53
 B&L Renu Products 5 17.24 13 34.21
 Alcon Optifree Products 0 0.00 7 18.42
 Hydrogen peroxide disinfectants 0 0.00 4 10.53
 Generic 4 13.79 3 7.89
 Other Soft Contact Lens Solutions 0 0.00 1 2.63
 Multiple Soft Contact Lens solutions 4 13.79 6 15.79
  AMO Complete MoisturePlus + additional soft contact lens solution 3 of 4 1 of 6
  B&L Renu + additional soft contact lens solution 1 of 4 5 of 6
  Alcon Optifree + additional soft contact lens solution 1 of 4 5 of 6
 Missing 1 1
Dichotomous solution use
 Exclusive use of AMO Complete MoisturePlus 16 55.17 4 10.53 67 17.76 2.23 141.22 0.007
 All other soft contact lens solutions use 13 44.83 34 89.47
 Missing 1 1
Multipurpose Solution Use
 Yes 29 100.00 32 84.21 67 4.91 0.64 0.139
 No 0 0.00 6 15.79
 Missing 1 1
Hydrogen Peroxide Use
 Yes 0 0.00 5 13.16 67 0.179 0 1.54 0.125
 No 29 100.0 33 86.84
 Missing 1 1
Saline Use
 Yes 2 6.90 5 13.16 67 0.58 0.01 8.36 p > 0.999
 No 27 93.10 33 86.64
 Missing 1 1
Daily Cleaner Use
 Yes 1 3.45 6 15.79 67 0.33 0.06 4.15 0.625
 No 28 96.55 32 84.21
 Missing 1 1
Enzyme Use
 Yes 1 3.45 3 7.89 67 1.41 0.02 117.66 p > 0.999
 No 28 96.55 35 92.11
 Missing 1 1

Lens-Handling Hygiene
Rub lenses when cleaning
 ≤ 10 times per month 20 76.67 20 53.85 65 2.54 0.61 10.56 0.200
 >10 times per month 7 23.33 18 46.15
 Missing 3 1
Wet hands while cleaning lenses
 >1 time per month 21 72.41 31 79.49 68 0.60 0.17 2.15 0.428
 0 times per month 8 27.59 8 20.51
 Missing 1 0
Rinse case with tap water
 >1 time per month 22 75.86 28 73.68 67 1.07 0.32 3.57 0.918
 0 times per month 7 24.14 10 26.32
 Missing 1 1
Shower with lenses
 >5 times per month 21 70.00 21 53.85 69 2.91 0.77 11.06 0.117
 0–5 times per month 9 30.00 18 46.15
 Missing 0 0
*

Exact conditional logistic regression used when necessary

Includes single use of all other products and also use of two or more products, including Complete MoisturePlus

Results

Between May 1, 2003 and September 15, 2006, 55 AK cases were identified. Two hundred sixteen contact lens-wearing controls matched on age and date-of-service were identified through clinic census data and medical record reviews to determine contact lens use status. Of these, 152 subjects agreed to participate and completed survey and water sampling packets, resulting in cooperation rates26 of 65.3% for controls and 73.6% for cases (Table 1). Of these, 38 cases and 100 controls were eligible based on complete data on contact lens use and use of contact lenses during the study period.

Thirty-five of 38 AK cases (92.1%) used soft contact lenses, as compared to only 47 of 100 (47%) controls (Table 2). Anecdotally, many soft contact lens controls were diagnosed with microbial keratitis, although this was not formally tracked. Of the 36 cases with complete data on solution use, 19 (52.8%) reported exclusive use of Complete MoisturePlus, as compared to only 7 of 100 (7.3%) unmatched controls and 4 of 39 (10.5%) matched soft contact lens controls (Tables 2 and 3; p < 0.0001).

Table 2.

Clinical characteristics of all enrolled Acanthamoeba keratitis cases and controls; all subjects used contact lenses.

Cases:
Acanthamoeba keratitis
Controls:
No Acanthamoeba keratitis
Chi-square p-value
Total
n = 38
% Total
n = 100
% Total n = 138

Use of soft contact lenses
 Yes 35 92.1 47 47.0
 No 3 7.9 53 53.0 p = <0.0001
Contact lens solution use
 Soft contact lens solutions
  AMO Complete MoisturePlus product* 19 52.8 7 7.3
  B&L ReNu products 6 16.7 14 14.6
  Alcon Optifree products 0 0.0 9 9.4
  Hydrogen peroxide disinfectants 0 0.0 4 4.2
  Generic products 4 11.1 4 4.2
  Other soft contact lens solution products 1 2.8 1 1.0
  Multiple soft contact lens solutions 4 11.1 9 9.4
   AMO Complete MoisturePlus + additional soft contact lens solution 3 of 4 2 of 9
   B&L Renu + additional soft contact lens solution 1 of 4 6 of 9
   Alcon Optifree + additional soft contact lens solution 1 of 4 7 of 9
 Rigid contact lens solutions
  Boston RGP products§ 0 0.0 36 37.5
  Lobob Optimum products** 0 0.0 9 9.4
  Other rigid contact lens solutions products 2 5.6 3 3.1
 Missing 2 6 p = <0.0001
*

AMO; Advanced Medical Optics, Santa Ana, CA

B&L; Bausch & Lomb, Rochester, NY

Alcon, Ft. Worth, TX

§

Polymer Technology Corp, Menomonie, WI

**

Lobob Laboratories, San Jose, CA

Matched analysis was limited to soft contact lens users because soft contact lens use between cases and controls was statistically different and solutions are unique to soft and rigid lenses. Matched analysis included 30 cases and 39 matched controls because 30 of 35 cases had matched controls and 39 of 47 controls had matched cases currently participating in the study. There were no statistically significant differences between cases and controls in demographic variables, suggesting soft contact lens controls were similar to cases. There was no statistically significant difference in overnight contact lens use, which is a known risk factor for general microbial keratitis (Table 3).2729

Cases were significantly more likely to report exclusive use of Complete MoisturePlus than controls (55.2% vs. 10.5%, respectively; OR, 17.76; 95% CI, 2.23 – 141.22; Table 3, Dichotomous solution use). Cases were also statistically more likely to report solution reuse or ‘topping off’ more than five times a month compared to five or fewer times per month (58.6% vs. 25.6%; OR, 3.19; 95% CI, 1.10 – 9.27; Table 3, Reuse solution).

Four hygiene-related variables demonstrated relatively strong measures of effect despite imprecise confidence intervals, including frequency of lens replacement, age of case at replacement, rubbing lenses while cleaning, and showering while wearing contact lenses (Table 3); the remaining variables resulted in non-statistically significant results. As such, multivariable analysis results adjusting for Complete MoisturePlus solution use and solution reuse or ‘topping off’ are presented in Table 4 and include these hygiene-related variables. Other variables with non-statistically significant results are excluded.

Table 4.

Conditional and Unconditional Multivariable* Odds Ratios and 95% Confidence Intervals for the Development of Acanthamoeba Keratitis among 30 Acanthamoeba keratitis cases and 39 clinic-matched controls wearing soft contact lenses.*

Conditional
Multivariable Analysis*
Unconditional
Multivariable Analysis*

Conditional OR§ 95% CI Chi-square p-value Unconditional OR** 95% CI Chi-square p-value

Exclusive use of Complete MoisturePlus solution (compared to all other solutions) 18.51 2.11 162.63 0.008 9.36 2.42 36.21 0.001
Reuse of solution >5 times per month (compared to 0–5 times per month) 3.17 0.82 12.33 0.096 4.20 1.25 14.10 0.020
“Rub” while cleaning lenses ≤ 10 times per month (compared to >10 times per month) 9.05 0.82 100.19 0.073 3.76 0.93 15.15 0.063
Shower while wearing lenses >5 per month (compared to 0–5 times per month) 9.07 0.68 120.72 0.095 2.36 0.64 8.71 0.198
Actual contact lens replacement quarterly or more frequent (compared to less frequent than quarterly) 0.42 0.07 2.61 0.348 0.60 0.16 2.30 0.456
Age of case at replacement >3 months (compared to ≤ 3 months) 2.79 0.56 13.98 0.212 1.97 0.52 7.46 0.318
*

The same subset of complete matched case-control pairs was used in each analysis

Both conditional and unconditional multivariable analysis results adjusted for significant variables in univariate analysis, including exclusive use of Complete MoisturePlus solution and reuse of solution >5 times per month

Unconditional analysis also adjusted for matching variables, including age (continuous) and date-of-service

§

Exact conditional logistic regression used when necessary

**

Exact unconditional logistic regression used when necessary

Self-reported use of Complete MoisturePlus was independently identified as a risk factor in multivariable analysis (OR, 16.67; 95% CI, 2.11 – 162.63; Table 4). The odds ratio for hygiene-related variables was strong despite imprecise confidence intervals (solution reuse more than five times per month compared to five or fewer times: OR, 3.17, 95% CI, 0.82 – 12.33; rubbing lenses ten or fewer times per month during cleaning compared to more than ten times: OR, 9.05, 95% CI, 0.82 – 100.19; shower with lenses more than five times per month compared to five or fewer times: OR, 9.07, 95% CI, 0.68 – 120.72).

Exact unconditional logistic multivariable regression demonstrated similar results in which exclusive use of Complete MoisturePlus was the strongest risk factor and a single hygiene-related variable became statistically significant while the rest remained non-significant (Complete MoisturePlus use: OR, 9.36, 95%CI, 2.42 – 36.21; solution reuse more than five times per month compared to five or fewer times: OR, 4.20, 95% CI, 1.25 – 14.10; Table 4).

Analyses performed with different dichotomous classifications of Complete MoisturePlus solution use, including restriction to single solution use and use of Complete MoisturePlus either alone or in combination with other solutions, resulted in consistent findings and identified Complete MoisturePlus use as independently associated with AK. The sensitivity analysis and also analysis of the subset of culture-positive cases (18 of 30 soft lens users) and their matched controls similarly identified Complete MoisturePlus use as independently associated with AK in multivariable analysis.

Discussion

These findings demonstrate that self-reported use of AMO Complete MoisturePlus Multi-Purpose Solution is an independent risk factor for AK among soft contact lens users. This is biologically plausible because in vitro studies demonstrate Acanthamoeba species are largely resistant to contact lens solutions in general,3039 and to Complete MoisturePlus in particular.30, 31, 39 Although solutions have been largely effective enough to prevent AK through the 1990’s16 up until 2003 when our outbreak began19 it is plausible that the recent AK outbreak may be due to a relative inability to withstand an Acanthamoeba challenge triggered by a higher microbial load related to potential outside issues, such as environmental- or hygiene-related factors.

A positive but statistically weak association was observed with conditional analysis between three hygiene-related variables (solution reuse, rubbing lenses, and showering with lenses) examined in our study; this association was consistent and strengthened in unconditional analysis. We did not find an association with overnight lens wear, however this may be artifactual due to the fact that we used a clinic-based control group and many had been diagnosed with microbial keratitis. The role that chance and various biases may play in these suggested associations needs to be clarified in larger studies; however, they are consistent with previous studies indicating poor hygiene in general as a risk factor.13, 16, 18 These hygiene-related factors are important as they may help prevent disease, and although AK is still rare among contact lens users, contact lens use is common with an estimated 36 million people using contact lenses in the United States.40 There have been published reports in the past year of increases in AK cases from multiple cities including Philadelphia,30 Portland, 31 San Francisco (Sansanayudh et al. IOVS 2007;48:ARVO E-Abstract 756), and Boston (Tanhehco et al. IOVS 2007;48:ARVO E-Abstract 754), suggesting an AK increase elsewhere, too. Although this analysis is restricted to soft contact lens wearers seen in the UIC Cornea Service in Chicago, risk factors investigated and identified in this analysis are not unique to Chicago. Because this AK outbreak represents the second concurrent outbreak of a rare and serious eye infection,19, 20 maintaining contact lens hygiene is prudent.

Additional risk factors beyond the identified solutions may be contributing to the dual increase in rare, contact-lens related keratitis caused by Acanthamoeba and Fusarium organisms. Complete MoisturePlus formulation changes in late 2002 roughly paralleled the onset of our outbreak; however, many cases did not use Complete MoisturePlus, suggesting inconsistencies in the simple assumption that the outbreak resulted from a product formulation change. In both the Acanthamoeba and Fusarium outbreaks, cases developing keratitis that did not use the affected solution exceeded the expected baseline occurrence of disease in contact lens wearers for each organism. Only 53% of AK cases used Complete MoisturePlus exclusively and 61% used Complete MoisturePlus either alone or in combination with other products; only 64% of Fusarium cases used Bausch & Lomb Renu MoistureLoc exclusively and 79% used MoistureLoc either alone or in combination with other products in the recent Fusarium keratitis outbreak investigation (Table 5; Bausch & Lomb, Rochester, NY).20 In addition, cases of contact lens-related Fusarium keratitis that never used MoistureLoc solution have been reported after MoistureLoc removal from the market (Jeng et al. Federated Scientific Societies Session, 2006).

Table 5.

Percentage of cases among contact lens users in either the Acanthamoeba or Fusarium keratitis outbreak investigations attributable to the specific solution independently identified as associated with keratitis. Analysis is restricted to soft contact lens users.

Fusarium Keratitis Outbreak 2006* Acanthamoeba Keratitis Outbreak 2003 – 2006
n % n %

Single solution use
 Use of solution that statistically significantly increased risk of disease, § single solution use only 94 64.4 19 52.8
 Use of other contact lens solutions, including use of multiple solutions 52 35.6 17 47.2
 Missing solution information 12 2
 Total 158 38
Multiple solution use
 Use of solution that statistically significantly increased risk of disease,§ either alone or in combination with other solutions 115 78.8 22 61.1
 Use of other contact lens solutions, excluding use of affected solutions 31 21.2 14 38.8
 Missing solution information 12 2
 Total 158 38
*

Chang et al., 2006

Current results from case-control study

Bausch & Lomb ReNu MoistureLoc for Fusarium keratitis outbreak

§

AMO Complete MoisturePlus MultiPurpose for Acanthamoeba keratitis outbreak

If suboptimal contact lens hygiene, such as reusing solution and not rubbing lenses during cleaning, contributes to increased biofilm on contact lenses, then Acanthamoeba exposure through shower aerosolization may contribute to disease, particularly if contact lens solutions are ineffective against Acanthamoeba. Showers have frequently been implicated as vectors in nosocomial infections through aerosolization of microbes,41 and Acanthamoeba have been isolated from the air,42, 43 making it plausible that exposure to Acanthamoeba organisms through showering while wearing contact lenses may contribute to AK disease. This possibility may be important if recent EPA regulations decreasing the allowable disinfection byproducts in the water supply have shifted the microbial risk,19, 21 effectively increasing the load of microbes from general water exposure that contact lens solutions must kill in order to avoid disease. In addition, Complete multipurpose solution is less effective than other multipurpose solutions against cysts and trophozoites when tested using multiple Acanthamoeba genotypes,39 as well as alternative amoebicidal efficacy testing techniques.30, 31

Analysis was restricted to soft contact lens use because the percentage of soft contact lens use between cases and controls was statistically different, reducing sample size. This differential soft lens use between cases and controls was unexpected based on previous AK series and laboratory studies, which suggest insufficient evidence to indicate differential AK risk among soft and rigid lens users. Control selection was not restricted to soft lenses as the percentage of soft lens use among contact lenses users in our AK series over time was between 85 – 95%, which approximates market shares40, 44 and is similar to soft lenses use in other AK series.3, 5, 13, 19, 22 Basic studies demonstrate nearly all U.S. rigid and soft contact lens solutions have at least some inadequacy in Acanthamoeba organism killing or inhibition.8, 3036 Results conflict as to whether Acanthamoeba organisms differentially adhere to soft and rigid lenses, although they appear to have greater adherence to newer silicone hydrogel lenses versus traditional soft hydrogel lenses.1, 612, 45 Because there was insufficient evidence to suggest differential AK risk among soft and rigid lens users, controls were recruited that used any contact lens type. Results from our case-control study seem to imply that soft contact lens use may increase AK risk; however, this likely represents an artifact of excessive rigid lens use among controls as soft lens use in 92% of contact lens-wearing AK cases is more consistent with market shares. Rigid lens use among patients seen in a cornea clinic may be higher than the general population due to the beneficial optical properties of rigid over soft lenses for certain corneal disorders.

The frequency of contact lens replacement may be important in AK disease, as worn lenses increase Acanthamoeba attachment, presumably from biofilms that develop as a result of tear film deposits.9, 10, 46 Our crude results based on the frequency of actual lens replacement (quarterly or more frequent vs. less frequent) did not demonstrate an effect between lens replacement and AK risk, however this result is likely confounded by many variables. It is plausible that older lenses may have a more highly developed biofilm than newer lenses, although the relationship is likely complex and may represent the culmination of all issues related to lens cleanliness if biofilm development is influenced by contact lens and tear film deposits, such as: individual tear film factors, lens material factors, solution efficacy factors, hygiene factors and lens age. Of these variables, the contact lens material FDA Lens Group appears to be more important than lens age or intersubject variability in predicting lens deposition,47, 48 and this FDA Lens Group is also critical in predicting Acanthamoeba adherence.11, 46, 4951 This suggests that lens material may actually confound our lack of association between the frequency of lens replacement and AK risk. Even so, as we had considerable survey item non-response to contact lens product manufacturer and brand name, we were unable to further investigate FDA lens material grouping (Table 2).

Another large category in soft lenses includes silicone hydrogel lenses, which represent significant advancements in soft contact lens technology that allows substantially more oxygen to the eye. This increased oxygen is believed to reduce the risk of severe adverse events,5255 although this effect has not definitively been confirmed through population-based studies.5658 On the other hand, Acanthamoeba appear to differentially adhere more strongly to silicone hydrogel lenses,9, 10, 45 but our results did not show an increase in AK risk with silicone hydrogel lens use. Within this analysis, no cases and only 25% of soft lens-wearing controls reported silicone hydrogel lens use, yet silicone hydrogel lenses accounted for 37% of 2006 U.S. retail contact lens sales.59 There was survey item non-response to contact lens product manufacturer and brand name, so misclassification potential for silicone hydrogel lens use exists (Table 2).

Potential misclassification effects resulting from analysis of all AMO Complete multipurpose solutions together are minimal. The outbreak continues unabated, and if related to the older formulation, the outbreak would have diminished, which is not the case. In addition, all cases reporting use of Complete multipurpose solutions were diagnosed after product launch of the newest formulation, AMO Complete MoisturePlus Multi-Purpose Solution. Based on a recent voluntary solution recall,60 most old branded formulations remain on the market a maximum of approximately 12 months until supplies are used (James Saviola, OD, FDA, personal communication, March 12, 2006); if this were the case then only five cases reporting use of the previous Complete formulation may be misclassified, which still would result in more than twice as many AK cases using Complete MoisturePlus compared to any other brand. With current classifications, there are three-times more AK cases using Complete MoisturePlus compared to any other solution brand. Finally, AC Nielsen reports that contact lens solution market shares for the entire AMO brand approximated only 10% of the contact lens solution business between April and June 2006.61 This suggests, strictly by crude analysis of market share, that only 10% of cases should be expected to report AMO use compared to other solutions, not the two- or three-fold increased reporting we find in our series. In comparison, only 10.5% of our soft lens controls reported Complete MoisturePlus use.

Several potential limitations exist within the study. First, clinic-based controls were used in order to further investigate the potential association between domestic water exposure and Acanthamoeba keratitis. Clinic-based controls are rarely considered either healthy or a random sample but simply ‘a sample’ of the source population, in part due to referral patterns.62, 63 Clinic-based controls should represent many diseases and no association should exist between the study exposure and the disease causing the clinic visit to prevent underestimation of the disease association;64 our controls included multiple diseases and there is no reason why study exposure, or use of Complete MoisturePlus, may result in controls requiring treatment at the UIC Cornea Service, hence our clinic-based control selection should lead to an appropriate effect measure (no fungal keratitis patients from the MoistureLoc outbreak20 were among controls). Furthermore, reported use of Complete MoisturePlus among controls closely mirrored market shares of AMO in the general population, supporting our selection of controls and suggesting that results may be generalizable to the population. WhIle the use of clinic-based controls including microbial keratitis cases may have biased the association between overnight contact lens use and Acanthamoeba keratitis as overnight contact lens use is a known risk factor for microbial keratitis, it is unlikely to have changed the associaiton between Complete MoisturePlus use and Acanthamoeba keratitis as reported use of Complete MoisturePlus among controls mirrored market shares.28, 56

In addition, as with any retrospective study of self-reported data, potential recall bias exists that may affect the association between Acanthamoeba keratitis and Complete MoisturePlus use. Because previous associations between Complete MoisturePlus and Acanthamoeba keratitis have not been reported, the likelihood of differential recall between cases and controls is small, minimizing the potential effect of recall bias. As well, images of solution bottles were incorporated into the questionnaire to assist all subjects in memory and minimize potential recall bias.

Finally, an oubtreak investigation of an extremely rare disease with limited cases may not have the statistical power to examine weaker disease associations. We attempted to mitigate this effect by including all cases of disease as defined by a very rigorous definition using multiple ancillary diagnositics tests, albeit a defintion not restricted exclusively to culture-positive cases. We think this is reasonable as Acanthamoeba culture positive rates are historically poor; for instance, Radford and Dart reported culture positive rates of 54% among 234 AK cases in 1992–96 and 43% among 106 AK cases in 1997–99 in an United Kingdom national survey.13, 22 Critical to this study, there was no inter-observer variability: all diagnostic tests and the clinical evaluation were performed by a single individual, who – by virtue of our AK outbreak with more than 60 cases to date and a culture isolation rate around 50% – has been trained on the execution and interpretation of these diagnostic tests with nearly immediate validation of interpretation. Although our choice of case definition may have resulted in potential disease misclassification and biased associations, we believe this is unlikely given our strict disease definitions, and actually preferential to more conservative culture-positive definitions that prevent exploration of valid secondary hypotheses. Furthermore, the association between Acanthamoeba keratitis and Complete MoisturePlus use persisted when analysis was restricted only to culture-positive cases, which demonstrates the robust nature of our results.

In summary, our findings identify self-reported AMO Complete MoisturePlus Multi-Purpose Solution among soft contact lens users as a risk factor for AK. This is evident not only when examining results from our case-control study, but also when crudely comparing solution market share to the percentage of AK cases using AMO Complete MoisturePlus. While the underlying mechanism for this risk remains unknown, none of the widely-used multipurpose solutions have been shown to be highly efficacious against Acanthamoeba; however they have generally been adequate to suppress large AK outbreaks in the past. 8, 3036 This suggests the risk presented by use of Complete MoisturePlus may be a relative inability to withstand an Acanthamoeba challenge compared to that of other solutions. Results similarly demonstrate non-statistically significant patterns of risk suggesting hygiene- and potentially water-related factors such as showering with contact lenses may contribute to AK. Despite the weak statistical association, these patterns may be important when taken into the context of a second unique outbreak of an extremely rare eye infection occuring in the same general time frame. In conclusion, our results demonstrate that use of AMO Complete MoisturePlus Multi-Purpose Solution is strongly associated with AK disease, but they also indicate that its use is not the only risk factor for disease. Continued research is warranted and ongoing to determine additional causes behind this AK outbreak and to evaluate whether potential shifts in the overall microbial load of the water supply may be contributing to this increase in disease.

Acknowledgments

Acknowledgments/Disclosure

a. Funding/ Support: NIH EY15689, NIH EY09073, Prevent Blindness America, Midwest Eye-Banks, UIC Campus Research Board, AOF AAO William C. Ezell Fellowship, Karl Cless Foundation

b. Financial Disclosures: None (CJ, MS, GB, PF, BA, MD, FD, LS); Lecture fees (ET, JS to Allergan; TM to Bausch & Lomb).

c. Contribution to Authors: Design of the study (CJ, ET, LS, FD, MD); Conduct of the study (CJ, ET); Collection of the data (CJ, ET, MS, GB); Management of the data (CJ); Analysis of the data (CJ, LS, BA); Interpretation of the data (CJ, ET, LS, FD, MD); Preparation of the manuscript (CJ, ET); Review of the manuscript (CJ, ET, MS, GB, PF, TM, BA, MD, JS, FD, LS); and Approval of the manuscript (CJ, ET, MS, GB, PF, TM, BA, MD, JS, FD, LS).

d. The University of Illinois at Chicago (UIC) Institutional Review Board reviewed and approved this research which was performed under HIPAA compliance with signed informed consent from subjects.

e. Special thanks to Jamie Brahmbhatt, COMT, University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences for serving as study coordinator and assisting in data collection.

Biographies

graphic file with name nihms28012b1.gif Charlotte Joslin, OD, is currently an Assistant Professor at the University of Illinois at Chicago, Department of Ophthalmology and Visual Sciences. Dr. Joslin received her undergraduate degree from Illinois Wesleyan University and professional degree from The Ohio State University, and completed her residency training at the VA Chicago Healthcare, West Side and Hines Divisions. She is currently a NEI K23 awardee and is a PhD candidate in epidemiology at the UIC School of Public Health.

graphic file with name nihms28012b2.gif Elmer Tu, MD, is currently an Associate Professor of Clinical Ophthalmology at the University of Illinois at Chicago serving as director of the Cornea and Refractive Surgery Service. Dr. Tu completed his residency at the University of Wisconsin-Madison and cornea fellowship at the Bascom Palmer Eye Institute in Miami. He was previously director of the Cornea and External Disease Service and Residency Program Director at the University of Texas Health Science Center, San Antonio.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Kilvington S, Larkin DF. Acanthamoeba adherence to contact lenses and removal by cleaning agents. Eye. 1990;4 ( Pt 4):589–93. doi: 10.1038/eye.1990.82. [DOI] [PubMed] [Google Scholar]
  • 2.Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD. Amoebic infection of the eye. Lancet. 1974;2:1537–40. doi: 10.1016/s0140-6736(74)90285-2. [DOI] [PubMed] [Google Scholar]
  • 3.Acanthamoeba keratitis associated with contact lenses--United States. MMWR Morb Mortal Wkly Rep. 1986;35:405–8. [PubMed] [Google Scholar]
  • 4.Stehr-Green JK, Bailey TM, Brandt FH, Carr JH, Bond WW, Visvesvara GS. Acanthamoeba keratitis in soft contact lens wearers. A case-control study JAMA. 1987;258:57–60. [PubMed] [Google Scholar]
  • 5.Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107:331–6. doi: 10.1016/0002-9394(89)90654-5. [DOI] [PubMed] [Google Scholar]
  • 6.Kelly LD, Long D, Mitra D. Quantitative comparison of Acanthamoeba castellanii adherence to rigid versus soft contact lenses. CLAO J. 1995;21:111–3. [PubMed] [Google Scholar]
  • 7.Sharma S, Ramachandran L, Rao GN. Adherence of cysts and trophozoites of Acanthamoeba to unworn rigid gas permeable and soft contact lenses. CLAO J. 1995;21:247–51. [PubMed] [Google Scholar]
  • 8.Cancrini G, Iori A, Mancino R. Acanthamoeba adherence to contact lenses, removal by rinsing procedures, and survival to some ophthalmic products. Parassitologia. 1998;40:275–8. [PubMed] [Google Scholar]
  • 9.Beattie TK, Tomlinson A, McFadyen AK. Attachment of Acanthamoeba to first-and second-generation silicone hydrogel contact lenses. Ophthalmology. 2006;113:117–25. doi: 10.1016/j.ophtha.2005.10.018. [DOI] [PubMed] [Google Scholar]
  • 10.Beattie TK, Tomlinson A, McFadyen AK, Seal DV, Grimason AM. Enhanced attachment of acanthamoeba to extended-wear silicone hydrogel contact lenses: a new risk factor for infection? Ophthalmology. 2003;110:765–71. doi: 10.1016/S0161-6420(02)01971-1. [DOI] [PubMed] [Google Scholar]
  • 11.Seal DV, Bennett ES, McFadyen AK, Todd E, Tomlinson A. Differential adherence of Acanthamoeba to contact lenses: effects of material characteristics. Optom Vis Sci. 1995;72:23–8. doi: 10.1097/00006324-199501000-00005. [DOI] [PubMed] [Google Scholar]
  • 12.Henriques M, Sousa C, Lira M, et al. Adhesion of Pseudomonas aeruginosa and Staphylococcus epidermidis to silicone-hydrogel contact lenses. Optom Vis Sci. 2005;82:446–50. doi: 10.1097/01.opx.0000168585.53845.64. [DOI] [PubMed] [Google Scholar]
  • 13.Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol. 2002;86:536–42. doi: 10.1136/bjo.86.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Meier PA, Mathers WD, Sutphin JE, Folberg R, Hwang T, Wenzel RP. An epidemic of presumed Acanthamoeba keratitis that followed regional flooding. Results of a case-control investigation. Arch Ophthalmol. 1998;116:1090–4. doi: 10.1001/archopht.116.8.1090. [DOI] [PubMed] [Google Scholar]
  • 15.Kilvington S, Gray T, Dart J, et al. Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. Invest Ophthalmol Vis Sci. 2004;45:165–9. doi: 10.1167/iovs.03-0559. [DOI] [PubMed] [Google Scholar]
  • 16.Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea. 1998;17:3–10. doi: 10.1097/00003226-199801000-00001. [DOI] [PubMed] [Google Scholar]
  • 17.Seal DV, Kirkness CM, Bennett HG, Peterson M. Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye. 1999;22:49–57. doi: 10.1016/s1367-0484(99)80003-4. [DOI] [PubMed] [Google Scholar]
  • 18.Lam DS, Houang E, Fan DS, Lyon D, Seal D, Wong E. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye. 2002;16:608–18. doi: 10.1038/sj.eye.6700151. [DOI] [PubMed] [Google Scholar]
  • 19.Joslin CE, Tu EY, McMahon TT, Passaro DJ, Stayner LT, Sugar J. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol. 2006;142:212–7. doi: 10.1016/j.ajo.2006.04.034. [DOI] [PubMed] [Google Scholar]
  • 20.Chang DC, Grant GB, O’Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953–63. doi: 10.1001/jama.296.8.953. [DOI] [PubMed] [Google Scholar]
  • 21.US Environmental Protection Agency: Stage 1 Disinfectants and Disinfection Byproducts Rule EPA 815-F-98-010, 1998.
  • 22.Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992–6. National Acanthamoeba Keratitis Study Group. Br J Ophthalmol. 1998;82:1387–92. doi: 10.1136/bjo.82.12.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Advanced Medical Optics. Advanced Medical Optics Announces It Is Launching COMPLETE MoisturePLUS. Press Release. 2003 [Google Scholar]
  • 24.Greenland S, Schwartzbaum JA, Finkle WD. Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol. 2000;151:531–9. doi: 10.1093/oxfordjournals.aje.a010240. [DOI] [PubMed] [Google Scholar]
  • 25.Checkoway H, Pearce N, Kriebel D. Research methods in occupational epidemiology. 2. xiv. New York: Oxford University Press; 2004. p. 372. [Google Scholar]
  • 26.Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006;163:197–203. doi: 10.1093/aje/kwj036. [DOI] [PubMed] [Google Scholar]
  • 27.Poggio EC, Glynn RJ, Schein OD, et al. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med. 1989;321:779–83. doi: 10.1056/NEJM198909213211202. [DOI] [PubMed] [Google Scholar]
  • 28.Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. N Engl J Med. 1989;321:773–8. doi: 10.1056/NEJM198909213211201. [DOI] [PubMed] [Google Scholar]
  • 29.Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet. 1999;354:181–5. doi: 10.1016/S0140-6736(98)09385-4. [DOI] [PubMed] [Google Scholar]
  • 30.Borazjani RN, Kilvington S. Efficacy of multipurpose solutions against Acanthamoeba species. Cont Lens Anterior Eye. 2005;28:169–75. doi: 10.1016/j.clae.2005.10.001. [DOI] [PubMed] [Google Scholar]
  • 31.Beattie TK, Seal DV, Tomlinson A, McFadyen AK, Grimason AM. Determination of amoebicidal activities of multipurpose contact lens solutions by using a most probable number enumeration technique. J Clin Microbiol. 2003;41:2992–3000. doi: 10.1128/JCM.41.7.2992-3000.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Buck SL, Rosenthal RA, Schlech BA. Amoebicidal activity of multipurpose contact lens solutions. Eye Contact Lens. 2005;31:62–6. doi: 10.1097/01.icl.0000146322.63546.50. [DOI] [PubMed] [Google Scholar]
  • 33.Hiti K, Walochnik J, Faschinger C, Haller-Schober EM, Aspock H. One- and two-step hydrogen peroxide contact lens disinfection solutions against Acanthamoeba: how effective are they? Eye. 2005;19:1301–5. doi: 10.1038/sj.eye.6701752. [DOI] [PubMed] [Google Scholar]
  • 34.Hiti K, Walochnik J, Maria Haller-Schober E, Faschinger C, Aspock H. Efficacy of contact lens storage solutions against different acanthamoeba strains. Cornea. 2006;25:423–7. doi: 10.1097/01.ico.0000214204.22200.7f. [DOI] [PubMed] [Google Scholar]
  • 35.Hughes R, Kilvington S. Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga. Antimicrob Agents Chemother. 2001;45:2038–43. doi: 10.1128/AAC.45.7.2038-2043.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Penley CA, Willis SW, Sickler SG. Comparative antimicrobial efficacy of soft and rigid gas permeable contact lens solutions against Acanthamoeba. CLAO J. 1989;15:257–60. [PubMed] [Google Scholar]
  • 37.Stevenson RW, Seal DV. Has the introduction of multi-purpose solutions contributed to a reduced incidence of Acanthamoeba keratitis in contact lens wearers? A review Cont Lens Anterior. Eye. 1998;21:89–92. doi: 10.1016/s1367-0484(98)80029-5. [DOI] [PubMed] [Google Scholar]
  • 38.Tzanetou K, Miltsakakis D, Droutsas D, et al. Acanthamoeba keratitis and contact lens disinfecting solutions. Ophthalmologica. 2006;220:238–41. doi: 10.1159/000093077. [DOI] [PubMed] [Google Scholar]
  • 39.Shoff M, Rogerson A, Schatz S, Seal D. Variable responses of Acanthamoeba strains to three multipurpose lens cleaning solutions. Optom Vis Sci. 2007;84:202–207. doi: 10.1097/OPX.0b013e3180339f81. [DOI] [PubMed] [Google Scholar]
  • 40.Barr JT. Contact Lens Spectrum. 2006. Annual Report Contact Lenses 2005. [Google Scholar]
  • 41.Breiman RF, Fields BS, Sanden GN, Volmer L, Meier A, Spika JS. Association of shower use with Legionnaires’ disease. Possible role of amoebae. JAMA. 1990;263:2924–6. [PubMed] [Google Scholar]
  • 42.Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol. 2004;34:1001–27. doi: 10.1016/j.ijpara.2004.06.004. [DOI] [PubMed] [Google Scholar]
  • 43.Rodriguez-Zaragoza S. Ecology of free-living amoebae. Crit Rev Microbiol. 1994;20:225–41. doi: 10.3109/10408419409114556. [DOI] [PubMed] [Google Scholar]
  • 44.McMahon TT, Zadnik K. Twenty-five years of contact lenses: the impact on the cornea and ophthalmic practice. Cornea. 2000;19:730–40. doi: 10.1097/00003226-200009000-00018. [DOI] [PubMed] [Google Scholar]
  • 45.Beattie TK, Tomlinson A, Seal DV. Surface treatment or material characteristic: the reason for the high level of Acanthamoeba attachment to silicone hydrogel contact lenses. Eye Contact Lens. 2003;29:S40-3. doi: 10.1097/00140068-200301001-00012. discussion S57-9, S192–4. [DOI] [PubMed] [Google Scholar]
  • 46.Simmons PA, Tomlinson A, Connor R, Hay J, Seal DV. Effect of patient wear and extent of protein deposition on adsorption of Acanthamoeba to five types of hydrogel contact lenses. Optom Vis Sci. 1996;73:362–8. doi: 10.1097/00006324-199606000-00002. [DOI] [PubMed] [Google Scholar]
  • 47.Jones L, Fcoptom, Mann A, Evans K, Franklin V, Tighe B. An in vivo comparison of the kinetics of protein and lipid deposition on group II and group IV frequent-replacement contact lenses. Optom Vis Sci. 2000;77:503–10. doi: 10.1097/00006324-200010000-00004. [DOI] [PubMed] [Google Scholar]
  • 48.Subbaraman LN, Glasier MA, Senchyna M, Sheardown H, Jones L. Kinetics of in vitro lysozyme deposition on silicone hydrogel, PMMA, and FDA groups I, II, and IV contact lens materials. Curr Eye Res. 2006;31:787–96. doi: 10.1080/02713680600888799. [DOI] [PubMed] [Google Scholar]
  • 49.Gorlin AI, Gabriel MM, Wilson LA, Ahearn DG. Binding of Acanthamoeba to hydrogel contact lenses. Curr Eye Res. 1996;15:151–5. doi: 10.3109/02713689608997408. [DOI] [PubMed] [Google Scholar]
  • 50.Simmons PA, Tomlinson A, Seal DV. The role of Pseudomonas aeruginosa biofilm in the attachment of Acanthamoeba to four types of hydrogel contact lens materials. Optom Vis Sci. 1998;75:860–6. doi: 10.1097/00006324-199812000-00007. [DOI] [PubMed] [Google Scholar]
  • 51.Lema I, Rodriguez-Ares MT, Gomez-Torreiro M, Penalver MD. Adherence of Acanthamoeba to unworn conventional and disposable soft contact lenses. Cornea. 2001;20:635–8. doi: 10.1097/00003226-200108000-00015. [DOI] [PubMed] [Google Scholar]
  • 52.Fonn D, Sweeney D, Holden BA, Cavanagh D. Corneal oxygen deficiency. Eye Contact Lens. 2005;31:23–7. doi: 10.1097/01.icl.0000151949.30730.9d. [DOI] [PubMed] [Google Scholar]
  • 53.Nilsson SE. Bacterial keratitis and inflammatory corneal reactions: possible relations to contact lens oxygen transmissibility: the Harold A. Stein Lectureship 2001 CLAO J. 2002;28:62–5. [PubMed] [Google Scholar]
  • 54.Cavanagh HD, Ladage P, Yamamoto K, Li SL, Petroll WM, Jester JV. Effects of daily and overnight wear of hyper-oxygen transmissible rigid and silicone hydrogel lenses on bacterial binding to the corneal epithelium: 13-month clinical trials. Eye Contact Lens. 2003;29:S14-6. doi: 10.1097/00140068-200301001-00005. discussion S26–9, S192–4. [DOI] [PubMed] [Google Scholar]
  • 55.Cavanagh HD, Ladage PM, Li SL, et al. Effects of daily and overnight wear of a novel hyper oxygen-transmissible soft contact lens on bacterial binding and corneal epithelium: a 13-month clinical trial. Ophthalmology. 2002;109:1957–69. doi: 10.1016/s0161-6420(02)01278-2. [DOI] [PubMed] [Google Scholar]
  • 56.Schein OD, McNally JJ, Katz J, et al. The incidence of microbial keratitis among wearers of a 30-day silicone hydrogel extended-wear contact lens. Ophthalmology. 2005;112:2172–9. doi: 10.1016/j.ophtha.2005.09.014. [DOI] [PubMed] [Google Scholar]
  • 57.Keay L, Edwards K, Naduvilath T, Forde K, Stapleton F. Factors affecting the morbidity of contact lens-related microbial keratitis: a population study. Invest Ophthalmol Vis Sci. 2006;47:4302–8. doi: 10.1167/iovs.06-0564. [DOI] [PubMed] [Google Scholar]
  • 58.Morgan PB, Efron N, Hill EA, Raynor MK, Whiting MA, Tullo AB. Incidence of keratitis of varying severity among contact lens wearers. Br J Ophthalmol. 2005;89:430–6. doi: 10.1136/bjo.2004.052688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Barr JT. Contact Lens Spectrum. 2007. Annual Report Contact Lenses 2006. [Google Scholar]
  • 60.Bausch & Lomb. Bausch & Lomb Initiates Limited Voluntary Recall of Twelve Lots of ReNu MultiPlus® Solution Due to Potential for Shortened Shelf Life. 2006 Press Release. [Google Scholar]
  • 61.Pagan Westphal S. Lens Case: Bausch & Lomb Solution Recall Exposes Risks for Eye Infections. The Wall Street Journal. 2006 [Google Scholar]
  • 62.Rothman KJ, Greenland S. Modern epidemiology. 2. xiii. Philadelphia, PA: Lippincott-Raven; 1998. p. 737. [Google Scholar]
  • 63.Cornfield J, Haenszel W. Some aspects of retrospective studies. J Chronic Dis. 1960;11:523–34. doi: 10.1016/0021-9681(60)90016-3. [DOI] [PubMed] [Google Scholar]
  • 64.Schlesselman JJ, Stolley PD. Case-control studies : design, conduct, analysis. xv. New York: Oxford University Press; 1982. p. 354. [Google Scholar]

RESOURCES